Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Meditope Biosciences Expands Patent Portfolio With Issuance Of Additional U.S. Patent

Meditope Biosciences
Posted on: 30 Aug 16

PASADENA, Calif., Aug. 30, 2016 /PRNewswire/ -- Meditope Biosciences, Inc., a biotechnology company developing novel antibody-based cancer products using its proprietary technology, today announced the issuance of an additional U.S. patent, U.S. Patent No. 9,428,553, entitled "Meditopes and Meditope-Binding Antibodies and Uses Thereof."

"We are excited by the continued momentum represented by this new U.S. patent, along with other recently-issued foreign patents. In addition to strengthening our intellectual property, it differentiates our novel antibody technology platform and validates the breadth of potential applications for our SnAP technology," said Stephanie Hsieh, Meditope's president and chief executive officer. "We believe these many potential applications of SnAP technology offer very compelling opportunities for the industry today, and we look forward to advancing our internal pipeline, while continuing to pursue partnership opportunities."

Meditope Biosciences now has eight issued patents worldwide related to its technology platform, including three in the United States.

About Meditope Biosciences, Inc. 
Meditope Biosciences is a biotechnology company developing novel antibody-based cancer products using its SnAP technology (Site-specific novel Antibody Platform).  Discovered at City of Hope, a National Cancer Institute designated Comprehensive Cancer Center, SnAP has the potential of turning any antibody into a proprietary, site-specific "LEGO-like" system that is able to attach and detach nearly anything to an antibody.  Meditope's SnAP technology has the potential to advance the antibody market by producing an array of new therapeutic and diagnostic products.  Visit

For more information:

Editor's Details

Mike Wood

Last updated on: 30/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.